Results 11 to 20 of about 4,703,837 (246)

Cardiovascular Safety Landscape of ADT in Prostate Cancer Treatment Based on Real-World Analysis. [PDF]

open access: yesCancer Med
Background Prostate cancer is among the most prevalent malignancies worldwide, and cardiovascular disease (CVD) is a major non‐cancer cause of death in affected patients. Androgen deprivation therapy (ADT), a mainstay treatment, has raised concerns about
Wang W   +7 more
europepmc   +2 more sources

Cardiovascular Agents

open access: yesSeminars in Dialysis, 2010
Ted Walton, Rebekah Thomas
openaire   +2 more sources

Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Narrative Review [PDF]

open access: yesAnnals of Geriatric Medicine and Research, 2021
While acetylcholinesterase inhibitors are used to treat a wide range of patients with Alzheimer’s disease, acetylcholinesterase inhibitor use has also been associated with a variety of cardiovascular complications, including bradycardia and syncope ...
Sara Young, Enoch Chung, Michael A. Chen
doaj   +1 more source

Persistence and Adherence to Cardiovascular Medicines in Australia

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia.
Juliana de Oliveira Costa   +5 more
doaj   +1 more source

The evidence for a role of bacteria and viruses in cardiovascular disease [PDF]

open access: yesScripta Medica, 2022
Inflammation plays a critical role in atherosclerosis and cardiovascular disease. Bacteria and viruses are major causative agents of inflammation in the body which normally develops as a response to infection.
Pierce Grant N.   +5 more
doaj   +1 more source

Evaluation of the Potentially Inappropriate Cardiovascular Medication Prescription in Elderly: A Nationwide Study in Turkey

open access: yesAnatolian Journal of Cardiology, 2023
Background: Elderly comprises a specific group due to possible alterations in the effects of drugs and comorbidities. We aimed to identify for the first time the characteristics and rates regarding the inappropriate prescriptions of cardiovascular system
Mehmet Tevfik Kitapçı   +5 more
doaj   +1 more source

Vasoactive-Inotropic Score and Vasoactive-Ventilation-Renal Score as Outcome Predictors for Children on Extracorporeal Membrane Oxygenation

open access: yesFrontiers in Pediatrics, 2021
We aimed to determine the association of vasoactive-inotropic score (VIS) and vasoactive-ventilation-renal (VVR) score with in-hospital mortality and functional outcomes at discharge of children who receive ECMO.
Ira Shukla   +3 more
doaj   +1 more source

A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives

open access: yesFrontiers in Pharmacology, 2021
Nowadays, nitrogenous heterocyclic molecules have attracted a great deal of interest among medicinal chemists. Among these potential heterocyclic drugs, benzimidazole scaffolds are considerably prevalent.
Shejuti Rahman Brishty   +5 more
doaj   +1 more source

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins

open access: yesDiabetes & Metabolism Journal, 2022
Statins are the cornerstone of the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However, even under optimal statin therapy, a significant residual ASCVD risk remains.
Kyuho Kim, H. Ginsberg, S. Choi
semanticscholar   +1 more source

Anti-angiogenetic agents against tumor types and cardiovascular risk

open access: diamondHellenic Journal of Cardiology, 2017
Panagiota Economopoulou   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy